Zynerba Pharmaceuticals Inc (ZYNE)

NASDAQ
4.01
-0.35(-8.03%)
After Hours
4.02
+0.01(+0.25%)
- Real-time Data
  • Volume:
    2,624,146
  • Bid/Ask:
    4.02/4.03
  • Day's Range:
    3.91 - 4.48

ZYNE Overview

Prev. Close
4.36
Day's Range
3.91 - 4.48
Revenue
-
Open
4.43
52 wk Range
3.12 - 9
EPS
-1.94
Volume
2,624,146
Market Cap
165.42M
Dividend (Yield)
N/A (N/A)
Average Vol. (3m)
3,524,495
P/E Ratio
-
Beta
2.53
1-Year Change
11.22%
Shares Outstanding
41,251,537
Next Earnings Date
May 11, 2021
What is your sentiment on Zynerba Pharmaceuticals Inc?
or
Market is currently closed. Voting is open during market hours.

Zynerba Pharmaceuticals Inc News

Zynerba Pharmaceuticals Inc Analysis

Technical Summary

Type
5 Min
15 Min
Hourly
Daily
Monthly
Moving AveragesBuySellSellStrong SellStrong Sell
Technical IndicatorsBuySellStrong SellStrong SellSell
SummaryBuySellStrong SellStrong SellStrong Sell

Zynerba Pharmaceuticals Inc Company Profile

Zynerba Pharmaceuticals Inc Company Profile

Employees
26

Zynerba Pharmaceuticals, Inc. is a specialty pharmaceutical company. The Company is engaged in developing and commercializing transdermal synthetic cannabinoid treatments for patients with high unmet needs. Its development pipeline includes two product candidates: ZYN002 and ZYN001. ZYN002 is a synthetic cannabidiol (CBD), which is a non-psychoactive cannabinoid, formulated as a patent-protected permeation-enhanced gel for transdermal delivery through the skin and into the circulatory system. ZYN002 is in Phase II clinical development in patients with refractory epilepsy, in patients with osteoarthritis of the knee, as well as in patients with Fragile X syndrome. ZYN001 is a pro-drug of tetrahydrocannabinol (THC) that enables transdermal delivery through the skin and into the circulatory system through a patch. ZYN001 is targeting two pain indications, fibromyalgia and peripheral neuropathic pain.

Read More
  • money in the bank just w8ing to buy the dip :D
    0
    • So, what do you think? I s this stock worth in the long term? (I am IN)
      0
      • This stock is nothing but the long term since thay have no product yet to sell:D
        0
      • This stock is nothing but the long term since thay have no product yet to sell:D
        0
    • gap defended two times with pretty candels, each dive to 3.7 zone is a buy! :P
      0
      • Hi
        1
        • alaike hi dadash, nazart chi dar morede in stocke?5.65 gerefte boodam alan ke oomder 3.91
          0
      • 9?  ))))
        0
        • matter of months if you have patience:)
          0
      • thanks
        0
        • buying more
          0
          • What do you think - an injection 3.15?
            0
            • and now retailers abandon the ship ;P
              1
              • time to load up
                0
                • buy?
                  0
                  • Finally on the way to 60
                    7
                    • nope not this year :D I only hope that this pump won't dump Zyne below 2.55...
                      0
                  • Wow. Shorts got crushed today. I know the feeling. Extremely painful bear trap. Hard to short a stock being pumped. Timing is pure luck.
                    0
                    • +20% on such low volume?? No resistance whatsoever :)
                      0
                      • lol 50% of float traded already with 5 times than average daily volume
                        0
                    • Is this recent rally driven by whole sector sentiment? Any1 have any news regarding  Zyne?
                      0
                      • other than some BUY ratings a few days ago, I can't seem to find ANY news that would justify such a jump, not even on the Zynerba website.
                        0
                      • exactly!! I was holding in red since past July, as it come on green I sold bc there were no news on zygel fda approval. Today it jumps without anything happening. I sure got upset, but there's nothing that I can find a justification for it...
                        0
                    • My free Robinhood stock. Lol.
                      0
                      • Same! ha!
                        0
                      • I wish I put some serious money into it. I didn't even look into it.
                        0
                    • Follow ocgn soon
                      0
                      • The biggest weekly volume ever on this stock is behind us, what will bring this week:)?
                        0
                        • Innovative Industrial Properties also good :-)
                          0
                          • ZYNE MAY HIT $10 HAS NEWS AND IS GOING TO DO GOOD TODAY I ALSO FOUND OUT  TYME STOCK TO RISE RAPIDLY TODAY WILL SURGE 300% DUE TO COVID NEWS READ GREAT NEWS https://cnafinance.com/tyme-stock-tyme-technologies VOLUME GOING UP BY THE SECOND The Latest Stock Market News and Opinion
                            1
                            • What Happened: GW Pharmaceuticals (NASDAQ:GWPH), which markets plant-derived cannabinoid epilepsy drug Epiodiolex, announced a deal to be bought by Jazz Pharmaceuticals (NASDAQ:JAZZ) for $7.2 billion in cash and stock. The Sympathy Move: The news has set in motion across-the-board strength in cannabinoid drug companies such as Corbus Pharmaceuticals Holdings Inc (NASDAQ:CRBP), Zynerba Pharmaceuticals Inc (NASDAQ:ZYNE), and Cara Therapeutics Inc (NASDAQ:CARA).
                              0
                              • Anybody knows what happened? Premarket highest price was 4,46
                                0
                                • Jazz Pharmaceuticals to acquire GW Pharma for $7.2 billion in cash and stock, GW soars 46% premarket. GW and Zyne are competitors
                                  0
                              • to the moon
                                0
                                • im afraid we need to find ground first to jump up... :(
                                  0
                              • since 3.5 is no longer support (no as solid as i thoght) now 2.55 b4 terra incgnita...
                                0
                                • tell me if im wrong. For now we know that zygel has great tolerance and is really effective with 12 months long treatment for epliepsy seizures. But there is plenty of different drugs with similar effectiveness on the market so nothing special no breakethrough. Main goal is to prove that it is effective with Fragile-X syndrom where for now there is no drug on the market and with that we still are hitting wall with zygel. If zyne proves it is statistically effective with 90% methylation – known as full methylation zyne might be the only one firm with such drug so it would be great.  If it fails zyne is done and dead.
                                  1
                                  Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All derived (stocks, indexes, futures), cryptocurrencies, and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn't bear any responsibility for any trading losses you might incur as a result of using this data.
                                  Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.